Firm
The five-partner team enhances Sheppard Mullin’s technology and life sciences capabilities, expanding its IP practice to more than 130 practitioners
Benjamin Grzimek, partner at Casalonga’s new Düsseldorf office, believes the firm is well-placed to challenge German UPC dominance
A lot of the reporting around the Anthropic settlement misses something critical: it isn’t that relevant to AI training, argues Rebecca Newman at Addleshaw Goddard
Justin Hill and Marie Jansson Heeks, part of an 18-strong team to have joined Crowell & Moring, explain why IP client advice must go beyond only being called upon for patent disclosure
Sponsored
Sponsored
-
Sponsored by CASBiologics intellectual property is complex and evolving rapidly, which makes effective searches vital. This CAS article presents expert strategies to address search challenges, protect innovations, and build stronger, litigation-ready patent programmes throughout the R&D life cycle -
Sponsored by Remfry & SagarRadha Khera and Sanhita Chatterjee of Remfry & Sagar explore how fashion brands are deploying AI, blockchain, and legal-tech tools to fight the escalating global threat of counterfeiting and protect brand integrity
-
Sponsored by ZaccoJoin Managing IP and Zacco on June 10 to explore why intellectual property due diligence is critical to investment and acquisition success. Learn what to look out for when evaluating an IP portfolio and product roadmap, maximising potential value and mitigating the risk of expensive surprises
-
Sponsored by ZaccoDesign rights are set to play an increasingly important role in strengthening global intellectual property strategies, say Tomas Wässingbo of Zacco and Christina Wainikka of the Confederation of Swedish Enterprise
-
Sponsored by TOPPAN Digital IPChris Evans of TOPPAN Digital IP outlines how AI, structured authoring, and secure technology are reshaping patent translation to improve quality, reduce costs, and accelerate international intellectual property filings in a managed environment
-
Sponsored by Wanhuida Intellectual PropertyHonghui Hu of Wanhuida Intellectual Property examines how the Supreme People’s Court has clarified the patent scope of drug combination inventions in a patent linkage dispute, offering rare guidance on claim interpretation of pharmaceutical combinations
